GRACE FOMUNUNG: Open Payments
NPI 1679028575 · DACULA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 59 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,394
Food & beverage: $1,394
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $262 |
| Otsuka America Pharmaceutical, Inc. | 11 | $233 |
| E.R. Squibb & Sons, L.L.C. | 6 | $140 |
| Neurocrine BioSciences, Inc. | 4 | $110 |
| Teva Pharmaceuticals USA, Inc. | 5 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Vanda Pharmaceuticals Inc. | 4 | $83 |
| Lundbeck LLC | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 2 | $66 |
Products named: REXULTI, Auvelity, COBENFY, INGREZZA, TRINTELLIX, CAPLYTA, LYBALVI, UZEDY.
Industry payments across GA — which companies pay providers there.
